Thorkell Snaebjörnsson1,2, Eric Hamrin-Senorski3, Eleonor Svantesson1, Louise Karlsson1, Lars Engebretsen4, Jon Karlsson1,2, Kristian Samuelsson1,2. 1. Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 2. Department of Orthopaedics, Sahlgrenska University Hospital, Mölndal, Sweden. 3. Department of Health and Rehabilitation, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 4. Oslo University Hospital, University of Oslo, Oslo, Norway.
Abstract
BACKGROUND: It is important to investigate and compare graft diameters as well as graft types to identify risk factors for revision after an anterior cruciate ligament (ACL) reconstruction. We performed the current study in order to analyze the early ACL revision rate among patients treated with hamstring tendon (HT) autografts or patellar tendon (PT) autografts of different diameters. Our hypothesis was that an increase in both HT and PT autograft diameters would reduce the risk of early ACL revision. METHODS: This retrospective study was based on prospectively collected data from the national knee ligament registries of Norway and Sweden and included patients who underwent primary ACL reconstruction during the period of 2004 through 2014. The primary end point was the 2-year incidence of ACL revision. The impact of graft type and diameter on the incidence of revision surgery was reported as relative risks (RRs) with 95% confidence intervals (CIs), estimated by using generalized linear models with a binomial distribution and log-link function. RESULTS: Of 58,692 patients identified, a total of 18,425 patients were included in this study. The 2-year rate of ACL revision was 2.10% (PT autografts, 2.63%; HT autografts, 2.08%; RR = 0.93 [95% CI = 0.60 to 1.45]). There was an increased risk of ACL revision among patients treated with HT autografts with a diameter of <8 mm compared with larger HT autografts (RR = 1.25 [95% CI = 1.01 to 1.57]). Patients treated with HT autografts with a diameter of ≥9.0 mm or ≥10.0 mm had a reduced risk of early ACL revision compared with patients treated with PT autografts. CONCLUSIONS: Patients treated with larger-diameter HT autografts had a lower risk of early ACL revision compared with those treated with HT autografts of <8 mm. Patients treated with HT autografts of ≥9 or ≥10 mm had a reduced risk of early ACL revision compared with patients treated with PT autografts. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
BACKGROUND: It is important to investigate and compare graft diameters as well as graft types to identify risk factors for revision after an anterior cruciate ligament (ACL) reconstruction. We performed the current study in order to analyze the early ACL revision rate among patients treated with hamstring tendon (HT) autografts or patellar tendon (PT) autografts of different diameters. Our hypothesis was that an increase in both HT and PT autograft diameters would reduce the risk of early ACL revision. METHODS: This retrospective study was based on prospectively collected data from the national knee ligament registries of Norway and Sweden and included patients who underwent primary ACL reconstruction during the period of 2004 through 2014. The primary end point was the 2-year incidence of ACL revision. The impact of graft type and diameter on the incidence of revision surgery was reported as relative risks (RRs) with 95% confidence intervals (CIs), estimated by using generalized linear models with a binomial distribution and log-link function. RESULTS: Of 58,692 patients identified, a total of 18,425 patients were included in this study. The 2-year rate of ACL revision was 2.10% (PT autografts, 2.63%; HT autografts, 2.08%; RR = 0.93 [95% CI = 0.60 to 1.45]). There was an increased risk of ACL revision among patients treated with HT autografts with a diameter of <8 mm compared with larger HT autografts (RR = 1.25 [95% CI = 1.01 to 1.57]). Patients treated with HT autografts with a diameter of ≥9.0 mm or ≥10.0 mm had a reduced risk of early ACL revision compared with patients treated with PT autografts. CONCLUSIONS:Patients treated with larger-diameter HT autografts had a lower risk of early ACL revision compared with those treated with HT autografts of <8 mm. Patients treated with HT autografts of ≥9 or ≥10 mm had a reduced risk of early ACL revision compared with patients treated with PT autografts. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
Authors: Volker Musahl; Ian D Engler; Ehab M Nazzal; Jonathan F Dalton; Gian Andrea Lucidi; Jonathan D Hughes; Stefano Zaffagnini; Francesco Della Villa; James J Irrgang; Freddie H Fu; Jon Karlsson Journal: Knee Surg Sports Traumatol Arthrosc Date: 2021-12-05 Impact factor: 4.342
Authors: Danilo Menghini; Shankar G Kaushal; Sean W Flannery; Kirsten Ecklund; Martha M Murray; Braden C Fleming; Ata M Kiapour; Benedikt Proffen; Nicholas Sant; Gabriela Portilla; Ryan Sanborn; Christina Freiberger; Rachael Henderson; Samuel Barnett; Yi-Meng Yen; Dennis E Kramer; Lyle J Micheli Journal: Orthop J Sports Med Date: 2022-10-14
Authors: Stephen Pui-Kit Tang; Keith Hay-Man Wan; Richard Hin-Lun Lee; Kevin Kwun-Hung Wong; Kam-Kwong Wong Journal: Asia Pac J Sports Med Arthrosc Rehabil Technol Date: 2020-08-12
Authors: Emily P Tran; Aleksei B Dingel; E Bailey Terhune; Nicole A Segovia; Brian Vuong; Theodore J Ganley; Peter D Fabricant; Daniel W Green; Tyler J Stavinoha; Kevin G Shea Journal: Orthop J Sports Med Date: 2021-04-27
Authors: Erick M Marigi; Bryant M Song; Jory N Wasserburger; Christopher L Camp; Bruce A Levy; Michael J Stuart; Kelechi R Okoroha; Aaron J Krych Journal: Orthop J Sports Med Date: 2022-05-05
Authors: Janina Kaarre; Bálint Zsidai; Eric Narup; Alexandra Horvath; Eleonor Svantesson; Eric Hamrin Senorski; Alberto Grassi; Volker Musahl; Kristian Samuelsson Journal: Curr Rev Musculoskelet Med Date: 2022-07-13
Authors: Maximilian Hinz; Christoph Lutter; Ralf Mueller-Rath; Philipp Niemeyer; Oliver Miltner; Thomas Tischer Journal: Knee Surg Sports Traumatol Arthrosc Date: 2022-09-25 Impact factor: 4.114
Authors: R Kyle Martin; Andreas Persson; Gilbert Moatshe; Anne Marie Fenstad; Lars Engebretsen; Jon Olav Drogset; Håvard Visnes Journal: Knee Surg Sports Traumatol Arthrosc Date: 2021-07-08 Impact factor: 4.114